版權(quán)說(shuō)明:本文檔由用戶(hù)提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、1664ASSESSMENTOFDRUGPRODUCTLEACHABLESASSOCIATEDWITHPHARMACEUTICALPACKAGINGDELIVERYSYSTEMSPURPOSEThisgeneralchapterpresentsaframewkfthedesignjustificationimplementationofassessmentsfdrugproductleachablesderivedfrompharmac
2、euticalpackagingdeliverysystems.Ascientificallysoundleachablesassessmentisimptanttomanufacturerstheirvarioussuppliersprimarilyasameansofestablishingthesuitabilityfuseofpharmaceuticalpackagingdeliverysystemsasleachablesca
3、npotentiallyaffectdrugproductefficacysafetyquality.Additionallysuchaleachablesassessmentcouldprovideanunderstingofthesourcesofleachableshowtoevaluatemanageleachablesduringthedrugdevelopmentmanufacturingprocesses.Thechapt
4、erestablishescriticaldimensionsofaleachablesassessmentdiscussespracticaltechnicalaspectsofeachdimension.Thechapterdoesnotestablishspecificanalyticalmethodsleachablesspecificationsacceptancecriteriafanyparticulardosagefmp
5、ackagingsystemdrugproductcombinationndoesitdelineateeverysituationinwhichaleachablesassessmentisrequired.Itisnotpossiblefageneraldiscussionofdrugproductleachablestoanticipatecoverallsituationswhichcanoccurinthepharmaceut
6、icalindustrywherealeachablesassessmentmightberequired.Designinganindividualleachablesassessmentisaprocessthatstrikesabalancebetweensoundscienceprudentresourceallocationeffectiveriskmanagementwithanemphasisonpatientsafety
7、productquality.Achievingthisbalanceistheresponsibilityobligationofthedrugproductmanufacturerassumesdueconsiderationofapplicablelegalregulatyrequirements.Theprinciplesbestdemonstratedpracticesoutlinedinthisgeneralchapterr
8、epresentaconsensusinterpretationofsoundsciencecantherefebeextrapolatedappliedtoanysituationinwhichaleachablesassessmentisrequiredfpharmaceuticalapplication.Inmanycasesdrugproductleachablesassessmentsarebasedonfacilitated
9、byknowledgefromextractablesassessmentsaccomplishedondrugproductpackagingsystemspackagingcomponentspackagingmaterialsofconstruction(seeAssessmentofExtractablesAssociatedwithPharmaceuticalPackagingDeliverySystems1663).KEYT
10、ERMSThisgeneralchapterusesthefollowingkeyterms(12alsoseePackagingStageRequirements659).NotethatthetermsPackagingSystemPackagingComponentPrimaryPackagingComponentSecondaryPackagingComponentMaterialsofConstructionarealsode
11、finedin659thedefinitionsbelowareintendedfclarificationpurposeswithinthecontextofthischapterarenotintendedtosupersedethoseprovidedin659.PackagingSystemsarethesumofpackagingcomponentsthattogethercontainprotectthedosagefm.P
12、ackagingsystemsarealsoreferredtoasContainerClosureSystemsmayincludeprimarysecondarytertiarypackaging.AContainerisareceptaclethatholdsanintermediatecompoundactivepharmaceuticalingredientexcipientdosagefmisindirectcontactw
13、iththeproduct.AClosureisamaterialthatsealsanotherwiseopenspaceonacontainerprovidesprotectionfthecontents.Italsoprovidesaccesstothecontentsofthecontainer.APackagingComponentisanysinglepartofthepackagecontainer–closuresyst
14、emincludingthecontainer(e.g.ampulsprefilledsyringesvialsbottles)closures(e.g.screwcapsstoppers)ferrulesoversealsclosurelinersinnersealsadministrationptsoverwrapsadminstrationaccessieslabelscardboardboxesshrinkwrap.APrima
15、ryPackagingComponentisindirectcontactmaycomeintodirectcontactwiththeproduct(e.g.IVbag).ASecondaryPackagingComponentisindirectcontactwithaprimarypackagingcomponentmayprovideadditionalprotectionoftheproduct(e.g.overpouchdu
16、stcoverfanIVbag).ATertiaryPackagingComponentisindirectcontactwithasecondarypackagingcomponentmayprovideadditionalprotectionoftheproductduringtransptationstage(e.g.shippingcartonfanoverpouchedIVbag).AnAncillaryComponentis
17、acomponententitythatmaycomeintocontactwithatertiarypackagingcomponentduringthedistributionstagetransptationofthepackagedproduct(e.g.palletsskidsshrinkwrapactivecontainers).PackagingMaterialsofConstructionaresubstancesuse
18、dtomanufacturepackagingcomponents.ThesearealsoreferredtoasRawMaterials.ADeliverySystemisthesumofcomponentsmaterialsthatareusedtotransptadrugproductfromitspackagingtothepointofadministrationintothepatient.Fexampleanadmini
19、strationsetisadeliverysystemthatisusedtotransferliquiddrugproductsfromtheirplasticpackagingsystemtothesiteofadministrationtothepatient.Extractablesareganicinganicchemicalentitiesthatcanbereleasedfromapharmaceuticalpackag
20、ingdeliverysystempackagingcomponentpackagingmaterialofconstructionintoanextractionsolventunderlabatyconditions.Dependingonthespecificpurposeoftheextractionstudy(discussedbelow)theselabatyconditions(e.g.solventtemperature
21、stoichiometryetc.)mayaccelerateexaggeratethenmalconditionsofstageusefapackageddosagefm.Extractablesthemselvessubstancesderivedfromextractableshavethepotentialtoleachintoadrugproductundernmalconditionsofstageusebecomeleac
22、hables.Thusextractablesarepotentialleachables.GeneralChapters18501664AssessmentofDrugProductLeachablesGeneralInfmationUSP39OfficialfromDecember12016Copyright(c)2016TheUnitedStatesPharmacopeialConvention.Allrightsreserved
23、.Accessedfrom10.6.1.1bycopps4onTueDec2720:14:28EST2016actionwithpackagingcomponents.Remainingrelativelyhighriskdosagefmsinclude:inhalationaerosolssolutionsinjectablesinjectablesuspensionsophthalmicstransdermalointmentspa
24、tches.Itisimptanttonotehoweverthatevenlowriskdosagefmspresentsomeriskthatappropriatelyrigousleachablesassessmentscanbeimptanttoparticulardrugproductsinlowerriskdosagefmcategies(e.g.topicalsaldosagefmsetc.).Table1.Modifie
25、dFDACDERCBERRiskBasedApproachtoConsiderationofLeachablesa(1)ExamplesofPackagingConcernsfCommonClassesofDrugProductsDegreeofConcernAssociatedwiththeRouteofAdministrationLikelihoodofPackagingComponentDosageFmInteractionHig
26、hMediumLowHighestInhalationAerosolsSpraysInjectionsInjectableSuspensionsInhalationSolutionsSterilePowdersPowdersfInjectionInhalationPowdersHighTransdermalOintmentsPatchesOphthalmicSolutionsSuspensionsNasalAerosolsSprays—
27、LowTopicalSolutionsSuspensionsTopicalLingualAerosolsalSolutionsSuspensions—alTabletsal(HardSoftGelatin)CapsulesTopicalPowdersalPowdersaWhilethistableprovidesaconvenientoverviewofthegenerallevelofregulatyconcernwithvariou
28、sdosagefmsregardingleachablesitshouldnotbeinferredthat“l(fā)owrisk”dosagefms(e.g.altablets)bythatdefinitioncarrynoriskfleachablesissues.Thischapterwilldescribescientificprinciplesbestpracticesftheassessmentofdrugproductleach
29、ableswillcovervariousimptantconceptsincluding:1)therequirementfleachablesstudies2)fundamentalconceptsfleachablesstudies3)thebasisofthresholdsfleachablesgeneralguidanceaboutapplicationofthesethresholds4)designimplementati
30、onofleachablesstudies5)leachablesmethoddevelopmentvalidation6)crelationofresultsfromextractablesassessmentsroutineextractablestestingwithleachablesstudies7)establishmentofleachablesspecificationsincludingacceptancecriter
31、ia.Thesescientificprinciplesbestpracticesapplytoallganizationsindividualsinvolvedinthemanufacturemarketingqualificationofdrugproductsintheirstabilitystudiesincludingbutnotlimitedto:?Manufacturersofdrugproductsfhumanveter
32、inaryusewheremanufacturingmayinvolveoperationsattheapplicantholdersfacilities(i.e.facilitiesthatbelongtotheholderofanapprovedNewDrugApplicationAbbreviatedNewDrugApplication)atthoseofacontractftheapplicantholder?Manufactu
33、rersofcombinationdrugproducts?Packagingoperationsbythemanufactureradesignatedcontractftheapplicantholder?Repackagingoperationsinwhichthedrugproductmaybeownedbyanganizationotherthantheprimarymanufacturer.Althoughitisultim
34、atelythedrugproductapplicantsresponsibilitytoensurethatappropriateleachablesassessmentsarecompletedmanufacturersfabricatsofpharmaceuticalpackagingdeliverysystemspackagingcomponentsmaterialsofconstructionshouldalsoapplyth
35、esescientificprinciplesbestpracticesasappropriateapplicantsareencouragedtowkwithcomponentmanufacturersfabricatstothisend.CONCEPTSGeneralConceptsfLeachablesAssessmentDuringthecourseofmanufacturingpackagingstagedistributio
36、nadministrationdosagefmstheirfmulationconstituentscontactcomponentsmaterialsofconstructionofmanufacturingpackagingequipmentprimarysecondarypackagingcomponentssystems.Suchcontactmayresultininteractionsbetweenthedosagefmth
37、esecomponentsmaterials.Onesuchinteractionisthemigrationleachingofsubstancesfromanyofthesecomponentsmaterialsintothedosagefm.Leachableswhichcanincludebothganicinganic(i.e.elemental)chemicalentitieswithwidechemicaldiversit
38、yareofconcernduetotheirpotentialsafetyrisktopatientspotentialcompatibilityrisksfthedrugproduct.Indertoassesstheserisksmanagethepotentialissuesposedbyleachablesitisnecessarytoknowtheiridentitiesthelevelstowhichtheywillacc
39、umulateinthefinisheddrugproductoveritsshelflife.Thesetwopiecesofinfmationcanbeusedtoestablishthemagnitudeofpatientexposure(dose)therefethesafetyriskposedbyanindividualleachableaswellasthelikelihoodofanydrugproductcompati
40、bilityissues.Regulatyguidelinesrequirementsvariousbestpracticerecommendationsallstatethatthedefinitiveassessmentofthepotentialimpactofcontactbetweenapackagingdeliverysystemafinaldosagefminvolvestestingthefinaldrugproduct
41、fleachables.Initsmostessentialfmthisimpactassessmentinvolvesperfmingamigrationleachablesstudywhosepurposeistodiscoveridentifyquantitateleachablesthathavemigratedfromthecontactedsystemcomponentsmaterialsaccumulatedinthefi
42、nisheddosagefmundertheproductsactualmanufacturingstageclinicaluseconditions.Aleachablesstudyisalabatyinvestigationintothequalitativequantitativenatureofaparticularleachablesprofile(s)overtheproposedshelflifeofaparticular
43、drugproduct.Thepurposeofaleachablesstudyistosystematicallyrationallyidentifyquantify(i.e.acterize)drugproductleachablestotheextentpracticablewithincertainGeneralChapters18521664AssessmentofDrugProductLeachablesGeneralInf
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶(hù)所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 眾賞文庫(kù)僅提供信息存儲(chǔ)空間,僅對(duì)用戶(hù)上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶(hù)上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶(hù)因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 包材檢驗(yàn)標(biāo)準(zhǔn)
- 包材采購(gòu)流程
- usp法定方法驗(yàn)證
- A公司包材庫(kù)存管理研究.pdf
- 包材采購(gòu)合同模版
- 包材類(lèi)檢驗(yàn)標(biāo)準(zhǔn)
- 包材產(chǎn)品haccp計(jì)劃
- 藥物與包材相容性研究
- 包輔材采購(gòu)單樣本
- 包材類(lèi)來(lái)料檢驗(yàn)規(guī)范
- 包材與藥物相容性研究匯總
- 化妝品包材驗(yàn)收標(biāo)準(zhǔn)
- 鐵水包耐材合同主要條款
- 關(guān)于采購(gòu)時(shí)候的包材知識(shí)
- 化妝品包材檢驗(yàn)標(biāo)準(zhǔn)
- 包材檢驗(yàn)質(zhì)量檢驗(yàn)標(biāo)準(zhǔn)
- 深藍(lán)筆記本維修初級(jí)(usp)筆記本維修包
- 06-原輔料包材危害分析表
- 淺析國(guó)產(chǎn)藥用玻璃包材市場(chǎng)及前景
- 包內(nèi)容物匯總
評(píng)論
0/150
提交評(píng)論